enVVeno Medical Corp
NVNO Nasdaq
SEC CIK 1661053
Follow enVVeno Medical
Weekly email: filings, results
Net income
−$4.4M
+3.8% vs same quarter last year
EPS, diluted
−$6.29
+20.3% vs same quarter last year
Operating cash flow
−$3.2M
+27.6% vs same quarter last year
Operating income
−$4.5M
+7.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | - | −$19.5M |
| FY24 | - | −$21.8M |
| FY23 | - | −$23.5M |
| FY22 | - | −$24.7M |
| FY21 | - | −$16.5M |
| FY20 | - | −$9.1M |
| FY19 | $31.2K | −$7.6M |
| FY18 | $186.6K | −$13M |
| FY17 | $422.1K | −$7.8M |
| FY16 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | - | - |
| FY24 | - | - |
| FY23 | - | - |
| FY22 | - | - |
| FY21 | - | - |
| FY20 | - | - |
| FY19 | −24566.5% | −24406.7% |
| FY18 | −4210.5% | −6991.5% |
| FY17 | −1445.9% | −1845.8% |
| FY16 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$15.6M |
| FY24 | −$16.9M |
| FY23 | −$18.9M |
| FY22 | −$15.7M |
| FY21 | −$12.2M |
| FY20 | −$7.9M |
| FY19 | −$6.3M |
| FY18 | −$6.4M |
| FY17 | −$4.2M |
| FY16 | - |
- enVVeno Medical
- Healthcare median
Show the numbers
| Year | enVVeno Medical | Healthcare median |
|---|---|---|
| FY25 | - | −30.6% |
| FY24 | - | −47% |
| FY23 | - | −58% |
| FY22 | - | −80.4% |
| FY21 | - | −71.8% |
| FY20 | - | −62.2% |
| FY19 | −24406.7% | −46.2% |
| FY18 | −6991.5% | −49.6% |
| FY17 | −1845.8% | −45.9% |
| FY16 | - | −36% |